A Study to Evaluate the Long Term Safety of OTX-TP (Sustained Release Travoprost) Intracanalicular Insert
Status:
Completed
Trial end date:
2020-09-22
Target enrollment:
Participant gender:
Summary
To evaluate the long term safety of repeat dose OTX-TP, a sustained release travoprost drug
product, placed in the canaliculus of the eyelid in the treatment of subjects with open-angle
glaucoma or ocular hypertension.